MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

Search

Odonate Therapeutics Inc

Fermé

0

Résumé

Variation du prix de l'action

24h

Actuel

Min

Max

Chiffres clés

By Trading Economics

Odonate Therapeutics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 janv. 2026, 22:41 UTC

Acquisitions, Fusions, Rachats

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 janv. 2026, 00:00 UTC

Résultats

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 janv. 2026, 23:47 UTC

Market Talk

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 janv. 2026, 23:44 UTC

Market Talk

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 janv. 2026, 23:39 UTC

Market Talk

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 janv. 2026, 23:32 UTC

Market Talk

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 janv. 2026, 22:56 UTC

Acquisitions, Fusions, Rachats

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 janv. 2026, 22:53 UTC

Acquisitions, Fusions, Rachats

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 janv. 2026, 22:17 UTC

Market Talk

Global Equities Roundup: Market Talk

14 janv. 2026, 22:17 UTC

Market Talk

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 janv. 2026, 22:09 UTC

Résultats

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 janv. 2026, 22:08 UTC

Résultats

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 janv. 2026, 22:08 UTC

Résultats

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 janv. 2026, 21:53 UTC

Acquisitions, Fusions, Rachats

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 janv. 2026, 21:53 UTC

Acquisitions, Fusions, Rachats

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 janv. 2026, 21:52 UTC

Acquisitions, Fusions, Rachats

WuXi XDC Announces Positive Profit Alert for 2025

14 janv. 2026, 21:51 UTC

Acquisitions, Fusions, Rachats

Citigroup Acting as Financial Advisor to WuXi XDC

14 janv. 2026, 21:51 UTC

Acquisitions, Fusions, Rachats

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 janv. 2026, 21:51 UTC

Acquisitions, Fusions, Rachats

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 janv. 2026, 21:50 UTC

Market Talk
Résultats

Financial Services Roundup: Market Talk

14 janv. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 janv. 2026, 21:49 UTC

Acquisitions, Fusions, Rachats

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 janv. 2026, 21:48 UTC

Acquisitions, Fusions, Rachats

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 janv. 2026, 21:48 UTC

Acquisitions, Fusions, Rachats

WuXi XDC Makes Cash Offer for BioDlink International

14 janv. 2026, 21:13 UTC

Market Talk

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 janv. 2026, 20:30 UTC

Market Talk
Résultats

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 janv. 2026, 20:13 UTC

Market Talk

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 janv. 2026, 20:08 UTC

Market Talk

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 janv. 2026, 19:33 UTC

Market Talk

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 janv. 2026, 19:06 UTC

Market Talk
Résultats

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Comparaison

Variation de prix

Odonate Therapeutics Inc prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

EBITDA

Bénéfice d'exploitation

$

À Propos Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat